LifeStance Health (LFST) Stock

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce the appointment of Andrea Judge as Chief Executive Officer of Lifeist Wellness Inc. effective today. Andrea, the current CEO of Lifeist's subsidiary Mikra Cellular Sciences Inc. (“Mikra”) since July 2024, will now lead Lifeist in its entirety.

New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Senft - William Blair Jamie Perse - Goldman Sachs Stephanie Davis - Barclays Operator Thank you for standing by. My name is Liz and I'll be your conference operator today.

LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago.

SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024.

Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare  SCOTTSDALE, Ariz. , Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure.

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the “Closing”) of CannMart Inc. (“CannMart”), a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, to Simply Solventless Concentrates Ltd.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc.(TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, Further to my previous letter of August 15, 2024, we wish to remind you of the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. (“CannMart”) via a sale to Simply Solventless Concentrates Ltd. (“SSC”) per our press release of June 25, 2024, and why shareholders should vote in favor of the transaction at the Annual and Special Meeting on September 5, 2024.